calcium gluconate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4348	299-28-5

Description:

Molecule	Description
Synonyms: calcium gluconate calciofon Calcium D-gluconate calcium gluconate monohydrate	The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states. Molecular weight: 430.37 Formula: C12H22CaO14 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 141.28 ALOGS: ROTB: None

Molecule

Description

Synonyms:

calcium gluconate
calciofon
Calcium D-gluconate
calcium gluconate monohydrate

The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states.

Molecular weight: 430.37
Formula: C12H22CaO14
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 141.28
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
3	g	O
3	g	P

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
None	FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Liver injury	582.04	13.50	317	26454	41531	56223765
Psoriatic arthropathy	431.98	13.50	324	26447	73684	56191612
Glossodynia	234.75	13.50	324	26447	152134	56113162
Pemphigus	219.70	13.50	319	26452	156893	56108403
Systemic lupus erythematosus	203.27	13.50	331	26440	179747	56085549
Arthropathy	189.02	13.50	340	26431	199935	56065361
Alopecia	155.69	13.50	394	26377	293064	55972232
Product use issue	150.74	13.50	296	26475	185745	56079551
Contraindicated product administered	137.32	13.50	285	26486	186001	56079295
Abdominal discomfort	133.39	13.50	359	26412	276915	55988381
Maternal exposure during pregnancy	92.57	13.50	247	26524	189306	56075990
Rheumatoid arthritis	73.80	13.50	368	26403	382236	55883060
Hand deformity	71.50	13.50	181	26590	134311	56130985
Prescribed overdose	70.90	13.50	69	26702	22227	56243069
Wound	70.89	13.50	184	26587	138620	56126676
Product complaint	67.36	13.50	51	26720	11709	56253587
Rheumatic fever	64.54	13.50	74	26697	28753	56236543
Fibromyalgia	63.60	13.50	107	26664	59496	56205800
Discomfort	58.61	13.50	174	26597	141587	56123709
Swollen joint count increased	54.00	13.50	62	26709	24122	56241174
Hip arthroplasty	53.23	13.50	78	26693	38545	56226751
Hypocalcaemia	53.19	13.50	67	26704	28693	56236603
Intentional product use issue	52.74	13.50	134	26637	99599	56165697
Product dose omission issue	49.11	13.50	18	26753	204735	56060561
Knee arthroplasty	47.93	13.50	80	26691	44179	56221117
Rheumatoid factor positive	47.66	13.50	103	26668	68957	56196339
Live birth	45.02	13.50	51	26720	19554	56245742
Fall	38.09	13.50	70	26701	357440	55907856
Anti-cyclic citrullinated peptide antibody positive	36.05	13.50	116	26655	98484	56166812
Blood cholesterol increased	35.77	13.50	95	26676	72484	56192812
Maternal exposure before pregnancy	35.60	13.50	28	26743	6795	56258501
Skin reaction	35.25	13.50	37	26734	13026	56252270
Type 2 diabetes mellitus	34.77	13.50	72	26699	46790	56218506
Pericarditis	33.55	13.50	121	26650	108802	56156494
Posthaemorrhagic hydrocephalus	31.60	13.50	6	26765	18	56265278
Dislocation of vertebra	29.94	13.50	23	26748	5392	56259904
Amnesia	29.59	13.50	67	26704	46255	56219041
Duodenal ulcer perforation	29.27	13.50	85	26686	68257	56197039
Adjustment disorder with depressed mood	28.93	13.50	22	26749	5081	56260215
Hiccups	27.41	13.50	15	26756	1973	56263323
Dyspnoea	27.15	13.50	168	26603	592409	55672887
Vascular access complication	26.68	13.50	14	26757	1693	56263603
Helicobacter infection	26.59	13.50	86	26685	73182	56192114
Recalled product	26.41	13.50	13	26758	1375	56263921
Hypercalcaemia	26.27	13.50	45	26726	25366	56239930
Injury	26.17	13.50	75	26696	59776	56205520
Suspected transmission of an infectious agent via product	25.57	13.50	8	26763	249	56265047
Blood calcium increased	25.48	13.50	25	26746	8129	56257167
Weight increased	25.31	13.50	44	26727	229659	56035637
Musculoskeletal deformity	25.24	13.50	13	26758	1513	56263783
Death	25.17	13.50	81	26690	341345	55923951
Nail infection	25.06	13.50	15	26756	2338	56262958
Infusion site reaction	24.61	13.50	16	26755	2882	56262414
Cystic fibrosis	24.42	13.50	17	26754	3427	56261869
Red cell distribution width decreased	24.37	13.50	13	26758	1626	56263670
Oedema	24.37	13.50	90	26681	81830	56183466
Treatment failure	24.11	13.50	151	26620	170241	56095055
Product compounding quality issue	23.69	13.50	5	26766	29	56265267
Synovitis	23.48	13.50	144	26627	161161	56104135
Distributive shock	23.12	13.50	11	26760	1080	56264216
Walking aid user	22.93	13.50	24	26747	8419	56256877
Colitis ischaemic	22.89	13.50	26	26745	9994	56255302
Swelling	22.71	13.50	193	26578	239578	56025718
Multiple drug therapy	22.70	13.50	15	26756	2777	56262519
Pain	22.53	13.50	441	26330	662743	55602553
Drug interaction	22.36	13.50	41	26730	209714	56055582
Culture positive	21.58	13.50	8	26763	420	56264876
Endometritis	21.00	13.50	10	26761	983	56264313
Neonatal infection	20.87	13.50	6	26765	139	56265157
Mean platelet volume decreased	20.84	13.50	13	26758	2181	56263115
Lupus vulgaris	19.77	13.50	12	26759	1917	56263379
Hyperdynamic left ventricle	19.65	13.50	6	26765	172	56265124
Poor peripheral circulation	19.58	13.50	15	26756	3502	56261794
Insomnia	19.15	13.50	39	26732	191821	56073475
Adverse drug reaction	18.90	13.50	71	26700	65061	56200235
Mobility decreased	18.82	13.50	95	26676	98896	56166400
Drug intolerance	18.55	13.50	200	26571	264618	56000678
Exercise tolerance decreased	18.42	13.50	17	26754	5121	56260175
Electrocardiogram U wave present	18.42	13.50	5	26766	93	56265203
Haemodynamic instability	18.00	13.50	21	26750	8308	56256988
Mucous stools	17.90	13.50	14	26757	3370	56261926
Pruritus	17.63	13.50	84	26687	316539	55948757
Mean cell volume decreased	17.59	13.50	14	26757	3454	56261842
Physical disability	17.53	13.50	12	26759	2355	56262941
Injection site pain	17.39	13.50	18	26753	117100	56148196
Hospitalisation	17.29	13.50	7	26764	74993	56190303
Prescribed underdose	16.87	13.50	33	26738	20584	56244712
CSF pressure increased	16.73	13.50	5	26766	133	56265163
Mean cell haemoglobin decreased	16.72	13.50	15	26756	4357	56260939
Colour blindness	16.66	13.50	6	26765	290	56265006
Hypertension	16.41	13.50	183	26588	244095	56021201
Exposure during pregnancy	16.36	13.50	116	26655	136226	56129070
Blood pressure inadequately controlled	16.28	13.50	15	26756	4509	56260787
Infusion related reaction	16.14	13.50	161	26610	208770	56056526
Influenza	16.09	13.50	13	26758	95248	56170048
Tetany	16.01	13.50	10	26761	1682	56263614
Wrong technique in product usage process	15.94	13.50	4	26767	58164	56207132
Pancreatitis chronic	15.51	13.50	11	26760	2283	56263013
Cytotoxic oedema	15.48	13.50	5	26766	173	56265123
Terminal ileitis	15.39	13.50	7	26764	620	56264676
Breast cancer stage III	15.38	13.50	18	26753	7145	56258151
Hepatic enzyme increased	15.19	13.50	136	26635	171248	56094048
X-ray abnormal	14.87	13.50	14	26757	4327	56260969
Anti-cyclic citrullinated peptide antibody	14.69	13.50	13	26758	3710	56261586
Electrocardiogram P wave abnormal	14.51	13.50	5	26766	212	56265084
Disability	13.82	13.50	26	26745	15754	56249542
Drug ineffective	13.72	13.50	550	26221	918439	55346857
Wheezing	13.56	13.50	71	26700	74955	56190341

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Toxic epidermal necrolysis	140.79	15.41	77	7828	19447	31669992
Hypocalcaemia	77.47	15.41	55	7850	21923	31667516
Lymphocyte count decreased	68.93	15.41	50	7855	20599	31668840
Cytokine release syndrome	50.37	15.41	38	7867	16604	31672835
Hypokalaemia	37.73	15.41	56	7849	53518	31635921
Red blood cells urine positive	31.77	15.41	13	7892	1709	31687730
Hyperkalaemia	31.40	15.41	57	7848	64294	31625145
Incision site pain	30.98	15.41	13	7892	1821	31687618
Blood urea increased	30.67	15.41	37	7868	28975	31660464
Protein urine present	28.93	15.41	17	7888	4903	31684536
Procedural pain	27.62	15.41	16	7889	4493	31684946
Benign abdominal neoplasm	27.17	15.41	6	7899	90	31689349
Neutrophil count increased	27.13	15.41	26	7879	15705	31673734
Posthaemorrhagic hydrocephalus	26.09	15.41	6	7899	109	31689330
Hypotension	25.74	15.41	110	7795	204508	31484931
Herpes zoster reactivation	25.35	15.41	7	7898	272	31689167
Product preparation error	24.46	15.41	11	7894	1821	31687618
Chest expansion decreased	24.31	15.41	6	7899	149	31689290
Immune effector cell-associated neurotoxicity syndrome	24.22	15.41	12	7893	2467	31686972
Wrong patient	23.29	15.41	6	7899	178	31689261
Multiple organ dysfunction syndrome	23.20	15.41	52	7853	68151	31621288
Blood creatinine increased	22.93	15.41	61	7844	89017	31600422
Cardiac arrest	21.93	15.41	60	7845	89002	31600437
Scrotal pain	21.13	15.41	8	7897	856	31688583
Lactobacillus test positive	20.41	15.41	4	7901	32	31689407
Blood albumin decreased	20.40	15.41	20	7885	12411	31677028
Hypercalcaemia	20.19	15.41	21	7884	13979	31675460
Delayed graft function	19.78	15.41	10	7895	2145	31687294
Pantoea agglomerans infection	19.70	15.41	4	7901	39	31689400
Axial spondyloarthritis	19.27	15.41	6	7899	356	31689083
Sepsis	18.55	15.41	81	7824	151848	31537591
Hypothalamo-pituitary disorder	18.18	15.41	7	7898	784	31688655
Respiratory failure	18.07	15.41	61	7844	101388	31588051
Hypoxia	17.82	15.41	39	7866	50274	31639165
White blood cell count increased	17.08	15.41	33	7872	38967	31650472
Bilirubin conjugated increased	16.26	15.41	10	7895	3131	31686308
Cyanosis	15.85	15.41	17	7888	11718	31677721

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Toxic epidermal necrolysis	116.99	12.48	104	25485	39453	70863402
Liver injury	107.89	12.48	101	25488	40934	70861921
Hypocalcaemia	107.68	12.48	105	25484	44754	70858101
Product complaint	88.22	12.48	55	25534	12176	70890679
Rheumatic fever	85.50	12.48	62	25527	17598	70885257
Swollen joint count increased	68.38	12.48	49	25540	13651	70889204
Psoriatic arthropathy	65.97	12.48	98	25491	64673	70838182
Completed suicide	63.08	12.48	5	25584	227130	70675725
Hip arthroplasty	51.71	12.48	57	25532	27983	70874872
Blood cholesterol increased	48.36	12.48	85	25504	64519	70838336
Knee arthroplasty	47.14	12.48	60	25529	34241	70868614
Hypercalcaemia	45.45	12.48	59	25530	34326	70868529
Pemphigus	44.68	12.48	95	25494	82941	70819914
Prescribed overdose	44.59	12.48	52	25537	27129	70875726
Glossodynia	44.31	12.48	97	25492	86390	70816465
Live birth	44.28	12.48	38	25551	13741	70889114
Fibromyalgia	43.89	12.48	69	25520	47805	70855050
Hand deformity	42.06	12.48	95	25494	86387	70816468
Product dose omission issue	37.09	12.48	16	25573	217452	70685403
Systemic lupus erythematosus	36.91	12.48	100	25489	101802	70801053
Maternal exposure during pregnancy	36.70	12.48	108	25481	115237	70787618
Drug abuse	36.36	12.48	5	25584	147251	70755604
Anti-cyclic citrullinated peptide antibody positive	36.27	12.48	79	25510	70106	70832749
Wound	35.87	12.48	97	25492	98635	70804220
Adjustment disorder with depressed mood	35.62	12.48	21	25568	4202	70898653
Blood calcium increased	35.60	12.48	28	25561	8965	70893890
Dislocation of vertebra	35.25	12.48	22	25567	4878	70897977
Type 2 diabetes mellitus	34.29	12.48	59	25530	44021	70858834
Discomfort	33.81	12.48	99	25490	105337	70797518
Hyperdynamic left ventricle	33.22	12.48	10	25579	363	70902492
Rheumatoid factor positive	32.80	12.48	61	25528	48339	70854516
Incision site pain	32.23	12.48	17	25572	2744	70900111
Musculoskeletal deformity	31.93	12.48	13	25576	1162	70901693
Alopecia	31.90	12.48	149	25440	198341	70704514
Fall	31.59	12.48	71	25518	444025	70458830
Pericarditis	31.55	12.48	84	25505	84621	70818234
Hypokalaemia	31.03	12.48	111	25478	131077	70771778
Lymphocyte count decreased	30.93	12.48	56	25533	43483	70859372
Nail infection	29.94	12.48	15	25574	2176	70900679
Vascular access complication	29.94	12.48	14	25575	1747	70901108
Culture positive	29.42	12.48	12	25577	1078	70901777
Suspected transmission of an infectious agent via product	29.21	12.48	12	25577	1097	70901758
Poor peripheral circulation	28.53	12.48	17	25572	3468	70899387
Red cell distribution width decreased	27.85	12.48	13	25576	1616	70901239
Death	27.71	12.48	93	25496	509968	70392887
Hyperkalaemia	27.64	12.48	93	25496	106498	70796357
Recalled product	27.52	12.48	11	25578	937	70901918
Cytokine release syndrome	26.87	12.48	40	25549	26427	70876428
Mean platelet volume decreased	26.51	12.48	14	25575	2265	70900590
Endometritis	25.93	12.48	10	25579	775	70902080
Arthropathy	25.85	12.48	115	25474	149942	70752913
Pantoea agglomerans infection	25.76	12.48	6	25583	78	70902777
Multiple organ dysfunction syndrome	24.96	12.48	91	25498	108424	70794431
Colitis ischaemic	24.79	12.48	28	25561	14109	70888746
Mobility decreased	24.22	12.48	87	25502	102912	70799943
Blood urea increased	24.08	12.48	52	25537	45857	70856998
Red blood cells urine positive	23.86	12.48	17	25572	4692	70898163
Infusion site reaction	23.83	12.48	14	25575	2783	70900072
Intentional product use issue	23.74	12.48	96	25493	120046	70782809
Walking aid user	23.61	12.48	21	25568	7960	70894895
Product compounding quality issue	23.45	12.48	5	25584	42	70902813
Small for dates baby	23.36	12.48	8	25581	441	70902414
White blood cell count increased	22.94	12.48	66	25523	69507	70833348
Protein urine present	22.46	12.48	22	25567	9418	70893437
Multiple drug therapy	22.13	12.48	14	25575	3178	70899677
Drug interaction	21.77	12.48	68	25521	381373	70521482
Duodenal ulcer perforation	21.42	12.48	53	25536	51059	70851796
Distributive shock	21.20	12.48	12	25577	2225	70900630
Neutrophil count increased	21.01	12.48	36	25553	26759	70876096
Chest expansion decreased	20.75	12.48	6	25583	189	70902666
Toxicity to various agents	20.52	12.48	70	25519	382102	70520753
Vaginal discharge	19.85	12.48	15	25574	4528	70898327
Benign abdominal neoplasm	19.72	12.48	6	25583	226	70902629
Helicobacter infection	19.52	12.48	54	25535	55602	70847253
Treatment failure	19.45	12.48	103	25486	144039	70758816
Synovitis	19.29	12.48	95	25494	129133	70773722
Lupus vulgaris	18.97	12.48	8	25581	781	70902074
Lactobacillus test positive	18.82	12.48	4	25585	33	70902822
Breast cancer stage III	18.62	12.48	17	25572	6664	70896191
Electrocardiogram U wave present	18.47	12.48	5	25584	123	70902732
Physical disability	18.45	12.48	12	25577	2855	70900000
Contraindicated product administered	18.03	12.48	96	25493	134516	70768339
Injury	17.87	12.48	58	25531	65187	70837668
Haemodynamic instability	17.84	12.48	25	25564	15633	70887222
Weight increased	17.81	12.48	38	25551	242293	70660562
Joint destruction	17.31	12.48	14	25575	4664	70898191
Disability	17.19	12.48	24	25565	14959	70887896
X-ray abnormal	17.18	12.48	11	25578	2549	70900306
Hypophosphataemia	17.04	12.48	25	25564	16301	70886554
Delayed graft function	16.88	12.48	12	25577	3301	70899554
Paraesthesia oral	16.66	12.48	24	25565	15393	70887462
Blister	16.53	12.48	76	25513	100450	70802405
Hepatic enzyme increased	16.50	12.48	105	25484	156885	70745970
Colour blindness	16.45	12.48	6	25583	398	70902457
Hiccups	15.99	12.48	18	25571	9034	70893821
Mean cell volume decreased	15.95	12.48	13	25576	4377	70898478
Tetany	15.91	12.48	10	25579	2244	70900611
Mean cell haemoglobin decreased	15.86	12.48	14	25575	5254	70897601
Wound infection	15.68	12.48	25	25564	17517	70885338
CSF pressure increased	15.62	12.48	5	25584	223	70902632
Exercise tolerance decreased	15.61	12.48	17	25572	8231	70894624
Dyspnoea	15.40	12.48	191	25398	769869	70132986
Axial spondyloarthritis	15.35	12.48	6	25583	482	70902373
Blood pressure inadequately controlled	15.14	12.48	14	25575	5578	70897277
Blood albumin decreased	15.13	12.48	28	25561	22099	70880756
Amnesia	14.86	12.48	47	25542	52108	70850747
Red blood cell sedimentation rate	14.69	12.48	13	25576	4897	70897958
Oedema	14.65	12.48	75	25514	103506	70799349
Prescribed underdose	14.54	12.48	27	25562	21358	70881497
Ileus	14.52	12.48	29	25560	24208	70878647
Hypoaesthesia	14.45	12.48	100	25489	153639	70749216
Acute respiratory distress syndrome	14.44	12.48	40	25549	41214	70861641
Burkholderia test positive	14.31	12.48	6	25583	578	70902277
Electrocardiogram T wave amplitude decreased	14.09	12.48	6	25583	600	70902255
Cardiovascular insufficiency	14.09	12.48	10	25579	2743	70900112
Hypertension	14.08	12.48	166	25423	295867	70606988
Electrocardiogram P wave abnormal	14.05	12.48	5	25584	309	70902546
Procedural pain	13.86	12.48	24	25565	17985	70884870
Alpha hydroxybutyrate dehydrogenase increased	13.34	12.48	3	25586	33	70902822
Terminal ileitis	13.34	12.48	6	25583	685	70902170
Abdominal discomfort	13.31	12.48	127	25462	214531	70688324
Cytotoxic oedema	13.21	12.48	5	25584	368	70902487
Septic shock	13.00	12.48	77	25512	112181	70790674
Shock	12.99	12.48	38	25551	40387	70862468
Laryngeal pain	12.98	12.48	13	25576	5715	70897140
Hypoalbuminaemia	12.83	12.48	24	25565	19098	70883757
Adverse drug reaction	12.48	12.48	45	25544	53299	70849556

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A12AA03	ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS CALCIUM Calcium
ATC	D11AX03	DERMATOLOGICALS OTHER DERMATOLOGICAL PREPARATIONS OTHER DERMATOLOGICAL PREPARATIONS Other dermatologicals
CHEBI has role	CHEBI:50733	Dietary Supplement

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Hypocalcemia	indication	5291005
Osteoporosis	indication	64859006	DOID:11476
Hypocalcemic tetany	indication	190869004
Necrotizing enterocolitis in fetus OR newborn	contraindication	2707005
Alcoholism	contraindication	7200002
Poisoning by digitalis glycoside	contraindication	12876009
Peptic ulcer	contraindication	13200003	DOID:750
Constipation	contraindication	14760008	DOID:2089
Hyperphosphatemia	contraindication	20165001	DOID:0050459
Hypervitaminosis D	contraindication	27712000	DOID:9971
Sarcoidosis	contraindication	31541009	DOID:11335
Dehydration	contraindication	34095006
Hypertensive disorder	contraindication	38341003	DOID:10763
Gastrointestinal ulcer	contraindication	40845000
Conduction disorder of the heart	contraindication	44808001
End stage renal disease	contraindication	46177005	DOID:784
Humoral hypercalcemia of malignancy	contraindication	47709007
Vitamin K deficiency	contraindication	52675005	DOID:11249
Nasal polyp	contraindication	52756005
Heart disease	contraindication	56265001	DOID:114
Acute nephropathy	contraindication	58574008
Hepatic failure	contraindication	59927004
Hypercalcemia	contraindication	66931009	DOID:12678
Hyperparathyroidism	contraindication	66999008	DOID:13543
Poisoning by acetaminophen	contraindication	70273001
Agoraphobia	contraindication	70691001	DOID:593
Ventricular fibrillation	contraindication	71908006
Hypercalciuria	contraindication	71938000
Factor II deficiency	contraindication	73975000
Reye's syndrome	contraindication	74351001	DOID:14525
Gastrointestinal hemorrhage	contraindication	74474003
Thrombotic thrombocytopenic purpura	contraindication	78129009	DOID:10772
Gout	contraindication	90560007	DOID:13189
Kidney disease	contraindication	90708001	DOID:557
Hemophilia	contraindication	90935002
Kidney stone	contraindication	95570007
Anemia due to enzyme deficiency	contraindication	111577008
von Willebrand disorder	contraindication	128105004	DOID:12531
Seizure disorder	contraindication	128613002
Obsessive-compulsive disorder	contraindication	191736004	DOID:10933
Insomnia	contraindication	193462001
Impaired renal function disorder	contraindication	197663003
Osteolysis	contraindication	203522001
Disease of liver	contraindication	235856003	DOID:409
Anemia	contraindication	271737000	DOID:2355
Pregnancy, function	contraindication	289908002
Thrombocytopenic disorder	contraindication	302215000	DOID:1588
Arteriosclerosis obliterans	contraindication	361133006	DOID:5160
Panic disorder	contraindication	371631005	DOID:594
Breastfeeding (mother)	contraindication	413712001
Myocardial ischemia	contraindication	414795007	DOID:3393
Myocardial infarction in recovery phase	contraindication	418044006
Acute erosive gastritis	contraindication	444926003

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Exclusivity date	Description
1GM/10ML (100MG/ML)	CALCIUM GLUCONATE	NIVAGEN PHARMS INC	A213071	Oct. 14, 2022	RX	SOLUTION	INTRAVENOUS	May 5, 2023	COMPETITIVE GENERIC THERAPY

Bioactivity Summary:

None

External reference:

ID	Source
4018087	VUID
N0000146426	NUI
D00935	KEGG_DRUG
4018087	VANDF
C0006699	UMLSCUI
CHEBI:3309	CHEBI
CHEMBL2106119	ChEMBL_ID
D002125	MESH_DESCRIPTOR_UI
DB11126	DRUGBANK_ID
66905-23-5	SECONDARY_CAS_RN
SQE6VB453K	UNII
9290	PUBCHEM_CID
1298846	RXNORM
20	MMSL
4337	MMSL
71865	MMSL
d03800	MMSL
000777	NDDF
007049	NDDF
387292008	SNOMEDCT_US
53691001	SNOMEDCT_US

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Calgonate Calcium Gluconate Gel2.5%	HUMAN OTC DRUG LABEL	1	0295-7520	GEL	2.50 g	TOPICAL	unapproved drug other	8 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	0404-9831	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	16 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	0404-9831	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	16 sections
Dairy Allergen Mix	HUMAN OTC DRUG LABEL	38	43742-1277	LIQUID	6 [hp_C]	ORAL	unapproved drug other	9 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	44567-620	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	22 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	44567-621	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	22 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	44567-622	INJECTION, SOLUTION	10 mg	INTRAVENOUS	NDA	22 sections
Calcium Gluconate	Human Prescription Drug Label	1	50090-3398	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	23 sections
CALCIUM GLUCONATE	HUMAN PRESCRIPTION DRUG LABEL	1	51662-1312	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	17 sections
CALCIUM GLUCONATE	HUMAN PRESCRIPTION DRUG LABEL	1	51662-1347	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	17 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	52584-360	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	15 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	63323-360	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	23 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	65219-162	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	23 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	65219-164	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	23 sections
Calcium Gluconate	HUMAN PRESCRIPTION DRUG LABEL	1	71872-7222	INJECTION, SOLUTION	98 mg	INTRAVENOUS	NDA	23 sections
calcium gluconate	Human Prescription Drug Label	1	75834-171	INJECTION, SOLUTION	98 mg	INTRAVENOUS	ANDA	23 sections